pt: told her insulin was limited to 4 units a day

A friend in Oregon had her meds denied by medicare today and was told her insulin was limited to 4 units a day denying her script for that too. The shit is getting deeper by the day but I am hopeful if you get involved with the politicians.

Oregon HERC Opioid Proposal Coming Up Thursday—Protestors Are Gearing Up

Oregon HERC Opioid Proposal Coming Up Thursday—Protestors Are Gearing Up

Oregon HERC Opioid Proposal Coming Up Thursday—Protestors Are Gearing Up

Meeting is suppose to start at  08/09/2018 1:30 PDT (4:30 EDT)

There is suppose to be a live feed of the meeting at:

We will be providing a webinar for those who are unable to attend in person: . Please feel free to share this with anyone who would like to view the meeting that way.

 

Maryland mom tests positive for opiates after eating poppy seed bagel

Maryland mom tests positive for opiates after eating poppy seed bagel

http://www.foxnews.com/health/2018/08/07/maryland-mom-tests-positive-for-opiates-after-eating-poppy-seed-bagel.html

A Maryland woman is blaming her false positive test for opiates on the breakfast she ate hours before giving birth. 

Elizabeth Eden was in labor at St. Joseph Medical Center in Towson last spring when doctors told her she tested positive for the drug. The new mother was shocked, especially when staff members told her she was being reported to the state.

“I was in labor. I was sitting in the bed. I was having contractions. I was on a Pitocin drip, and the doctor came in and said, ‘You’ve tested positive for opiates,'” Eden described to WBAL-TV.

Confused, Eden wasn’t sure what would have caused the false positive — but then she recalled the poppy seed bagel she had eaten earlier that day. Eden had learned in a school health class that eating poppy seeds could cause a false positive.

“I said, ‘Well, can you test me again? And I ate a poppy seed bagel this morning for breakfast,’ and she said, ‘No, you’ve been reported to the state,'” Eden told the news station.

For years, experts have confirmed that poppy seeds can register as opiates in urine samples, as long as they were eaten within 48 hours of the test.

“While poppy seeds don’t actually contain morphine, the seeds can become coated by, or absorb, opium extract during harvesting,” the United States Department of Agriculture explains on its website. “Opium is the milky substance that is extracted along with the poppy seeds from the seed pod of the opium poppy after all the petals have fallen off.”

Therefore, it’s possible for people to have a false positive test for the drug after consuming poppy seed-covered pasteries.

The test result meant Eden’s daughter had to stay in the hospital for five days in April while her mother was assigned a case worker. Eventually, after Eden explained the situation, the case worker closed the case.

The Federal Institute for Risk Assessment writes that until food manufacturers reduce morphine levels in poppy seeds, it advises against excessive consumption, particularly during pregnancy.

Arkansas Medical Licensing Board – cutting opiates for all pts ?

Oregon Patient Advocate can be heard tonight -08/07/2018

 

With most OD’s on ILLEGAL OPIATES Rep McSally wants to increase tracking of legal prescriptions

McSally proposes drug monitoring best-practices bill to combat nation’s opioid epidemic

www.riponadvance.com/stories/mcsally-proposes-drug-monitoring-best-practices-bill-to-combat-nations-opioid-epidemic/

Toward ending the nation’s opioid crisis in her home state and around the country, U.S. Rep. Martha McSally (R-AZ) on July 26 introduced the Prescription Drug Monitoring Program (PDMP) Best Practices Act.

“This crisis has plagued Arizona for too long,” Rep. McSally said. “We’ve taken steps to combat this epidemic but there’s still more work to be done.”

She said that’s why she introduced H.R. 6608, which would direct the U.S. Department of Justice’s Bureau of Justice Assistance to coordinate with the Centers for Disease Control and Prevention to develop best practice guidelines to bolster PDMPs, the electronic databases that track each state’s opioid prescriptions. H.R. 6608 also would simplify states’ adoption of PDMPs and establish a PDMP data-sharing pilot program for states.

“The opioid epidemic has torn apart families and ruined lives forever,” the congresswoman said, noting that 116 Americans die each day from a drug overdose.

“These victims come from every background – they are teachers, ranchers, retirees, and students,” she said. “No parent should have to bury their own child.”

Rep. McSally’s statement also pointed out that PDMPs may work as a powerful tracking tool to deter the misuse of controlled substances.

If enacted, H.R. 6608 would authorize guidance on the specific information that should be submitted to PDMPs, including the patients at the highest risk for misusing controlled substances and how to identify incorrect prescription trends. Additionally, guidance would focus on the best practices on treatment options for prescribers, and how to spot and address roadblocks to implementing the guidelines, according to McSally’s statement.

H.R. 6608, which is cosponsored by U.S. Rep. Kevin Cramer (R-ND), has been referred to the U.S. House Energy and Commerce Committee for consideration.

Addiction to Rx Opioids Falling

www.painnewsnetwork.org/stories/2018/7/14/addiction-to-rx-opioids-falling

A new report from health insurance giant Blue Cross Blue Shield highlights a little-known and rarely reported aspect of the opioid crisis: Addiction to opioid pain medication is declining, not increasing.

Blue Cross Blue Shield (BCBS) said 241,900 of its members were diagnosed with opioid use disorder (OUD) in 2017, a rate of 6.2 for every 1,000 BCBS members. The rate fell to 5.9 in 1,000 members in 2017, a decline of nearly 5 percent. The insurer said it was the first drop in the eight years BCBS has tracked diagnoses of OUD.

“We are encouraged by these findings, but we remain vigilant,” said Trent Haywood, MD, senior vice president and chief medical officer for BCBS said in a statement.

“More work is needed to better evaluate the effectiveness of treatment options and ensure access to care for those suffering from opioid use disorder.”

BCBS attributes much of the decline to a 29% drop in opioid prescriptions for its members since 2013.  A longtime critic of opioid prescribing hailed the findings as a sign of change.

bigstock-Addiction-504665.jpg

“It means that there’s light at the end of the tunnel,” psychiatrist Andrew Kolodny, MD, the founder and executive director of Physicians for Responsible Opioid Prescribing (PROP) told BuzzFeed.

“Unfortunately though, the genie is out of the bottle,” said Kolodny, a former medical director of the addiction treatment chain Phoenix House. “Millions of Americans are now struggling with opioid addiction. Unless we do a better job of increasing access to effective treatment, overdose deaths will remain at record high levels and we’ll have to wait for this generation to die off before the crisis comes to an end.”

Admissions for Addiction Treatment

The BCBS numbers should be taken with a grain of salt, since they include all types of opioid addiction, including those linked to heroin, illicit fentanyl and prescription opioids. A more accurate way to track addiction to opioid medication would be admissions to publicly-funded treatment facilities for “non-heroin opiates/synthetic abuse” – a category that excludes heroin, but includes hydrocodone, oxycodone, fentanyl and other painkillers.

A database maintained by the Substances Abuse and Mental Health Services Administration (SAMHSA) shows that treatment admissions for prescription opioids peaked in 2011 at 193,552 admissions and fell to 121,363 by 2015 – a significant decline of over 37 percent. It seems likely that admissions for painkiller abuse have fallen even further since 2015, as opioid prescriptions have continued to plummet, and more pain patients are abandoned or denied treatment.

The SAMHSA data also reveals another trend: While the number of people seeking treatment for painkiller, alcohol and marijuana abuse has declined, admissions to treatment facilities for heroin addiction have soared. In 2010, there were 270,564 admissions in which heroin was identified as the primary substance of abuse. By 2015, that number had grown to 401,743 admissions – an increase of nearly a third.

ADMISSIONS TO ADDICTION TREATMENT FACILITIES

  • Heroin
  • Rx Opioids
  • Alcohol
  • Marijuana
SOURCE: SAMHSA

Admissions for heroin addiction now surpass those for other substances, yet much of the nation’s spending and law enforcement resources remain targeted on opioid prescriptions. Many public health officials also cling to the myth the heroin epidemic was triggered by opioid overprescribing, even though heroin admissions outnumber painkiller admissions by a 3 to 1 margin.

“Epidemiological data show that as widely prescribed opioids became less accessible due to supply side interventions, heroin use skyrocketed,“ psychiatrist Nora Volkow, MD, director of the National Institute on Drug Abuse, recently told OpioidWatch.  Volkow was an early supporter of the CDC opioid guideline, one of the first supply side interventions, a strategy that she now characterizes as “naive.”

“Expecting that declines in rates of prescribed opioids could, by themselves, stem the tide of the opioid crisis is naïve and an oversimplification of the complex nature of the crisis,” Volkow said. “Legitimate questions have been raised about whether some pain patients might now be undertreated, and whether tightened prescribing practices over the last few years has contributed to the surge in overdose deaths from heroin and especially fentanyl.”

A recent study by SAMHSA found that deaths linked to illicit fentanyl and other synthetic opioids surpassed overdoses involving pain medication in 2016.  The study also found that drugs used to treat depression and anxiety are involved in more overdoses than any other class of medication.

“In 2010, there were 270,564 admissions in which heroin was identified as the primary substance of abuse. By 2015, that number had grown to 401,743 admissions – an increase of nearly a third.”

These people can’t even do SIMPLE MATH…

A INCREASE from 270,564 to 401,743 is nearly a 50% INCREASE…

IF there had been a reduction from 401,743 to 270,564 would have been a DECREASE of 30%

With these people … I wonder if 2+2 is still equal to FOUR ?

Lexington doctor who exposed Kentucky hospital to be featured on CBS show.

Lexington doctor who exposed Kentucky hospital to be featured on CBS show.

https://www.kentucky.com/news/local/crime/article216037450.html

Dr. Michael Jones, an interventional cardiologist with Baptist Health Medical Group Lexington Cardiology, practices at Baptist Health Lexington.

A Lexington doctor who helped uncover a widespread false billing scheme at a Kentucky hospital will be featured on CBS’ Whistleblower Friday night.

Whistleblower, airing at 9 p.m. Friday, features stories “of heroic people who put everything on the line in order to expose illegal and often dangerous wrongdoings,” according to its website.

Friday’s episode showcases Dr. Michael Jones, who along with fellow doctors Paula Hollingsworth and Michael Rukavina in 2010 and 2011, played a key role in blowing the whistle on an alleged overbilling scheme at St. Joseph-London Hospital.

The doctors noticed when they treated patients who had heart procedures done at St. Joseph-London that the treatments had been unnecessary, according to a lawsuit they jointly filed in 2011. One patient in London had 17 unneeded heart catheterizations and another patient had 10 catheterization procedures and seven stents placed to improve blood flow near arteries that were near normal.

St. Joseph-London and some doctors who worked there were accused of submitting bills to government-funded programs such as Medicare and Medicaid for hundreds of unnecessary heart procedures.

The alleged wrongdoings occurred before St. Joseph merged with Jewish Hospital and St. Mary’s HealthCare in 2012 to form KentuckyOne Health.

The owner of St. Joseph-London agreed to pay a $16.5 million settlement, which was the second-largest ever in a health care fraud case in the federal Eastern District of Kentucky.

The settlement resolved the claims against the hospital, but several doctors who practiced at the hospital and their clinics were also sued by patients.

Jones decided to take action because the procedures were invasive and costly enough to potentially bankrupt patients.

“I saw many patients who underwent unnecessary heart procedures,” Jones said, according to a release from CBS. “I was concerned they were being done for financial gain.”

Kevin Wells had a pacemaker installed that was unwarranted. His wife, Ruth Wells, is a part of the CBS episode. She said Kevin’s heart felt like it was beating out of his chest.

“Kevin could have died,” Ruth Wells said, according to CBS. “He could have died on that table. And to think it was for something he didn’t need.”

Jones practices at Baptist Health Lexington.

A statement provided by KentuckyOne Health Friday stated the London hospital is demonstrating clear action to prevent this issue from recurring.

“In February 2011, following a months-long internal investigation, Saint Joseph London self-reported to Federal authorities instances of interventional cardiology procedures that lacked adequate documentation to support the clinical indication for the procedures. The internal investigation was launched as a result of the hospital’s own proactive and ongoing compliance reviews, and the hospital then self-reported to Federal authorities, one month prior to the whistleblower lawsuit,” according to the statement.

“Saint Joseph London also fully cooperated in all subsequent government inquiries concerning the interventional cardiology procedures,” the statement continued. “Since then, the hospital has demonstrated clear action to address and prevent this issue from recurring, including monitoring, reporting and ongoing audits that exceed governmental requirements. In fact, in 2017 Saint Joseph-London was recognized by the Accreditation for Cardiovascular Excellence as adhering to the highest quality standards for cardiovascular care.”

Interventional pain procedures

Interventional pain management can help manage some patient’s pain. Many interventional pain procedures are complex and require the use of advanced imaging techniques such as fluoroscopy, digital subtraction, angiography and computerized tomography to accurately guide needles to the proper location to treat pain.
How many pts have had ESI and other procedures that have provided little/no short or long term benefits … sometimes make things worse and there are some estimated 10 million ESI done every year and it is estimated that 5% will end up with  https://en.wikipedia.org/wiki/Arachnoiditis
A very painful condition which cannot be reversed and is caused by a ESI injection where the needle penetrates the spinal cord and the ESI medication is injected into the spinal fluid.  These ESI’s are normally performed by INTERVENTIONAL PAIN doctors… typically anesthesiologists.
I have read many statements from pts from numerous “pain clinics” that the pts are told that unless you submit to ESI procedures… the pts will not be provided any oral opiates for their pain.
The medication typically used Methylprednisolone is not recommended by the FDA nor the UpJohn company to be used in ESI’s.
Typically, these ESI should only be used as a diagnostic tool. If after a series of ESI and the pain is not resolved.. .then the cause of the pain is not ACUTE and is CHRONIC and does not warrant continue the administration of ESI’s.
Is the title of Interventionalist a euphemism for fraudulent care  ?

65,000 + pharmacies in the USA and they are only suing TWO CHAINS – “DEEP POCKETS LAWSUIT” ?

City, county governments file suit against opioid makers, pharmacists

http://www.joplinglobe.com/news/city-county-governments-file-suit-against-opioid-makers-pharmacists/article_b172527e-9685-11e8-912d-03b3f4dc1fc8.html

Several Missouri county and municipal governments, including Joplin and Jasper County, on Wednesday officially filed a lawsuit against opioid manufacturers, pharmaceutical companies and pharmacies.

The suit, filed in Missouri’s 22nd circuit court in St. Louis, alleges multiple instances of misconduct on the part of the defendants with respect to the marketing of Oxycontin, a prescription opioid, and the distribution and management of those medications. The city of Joplin and Jasper County join Jefferson, Cape Girardeau, Christian, Crawford, Greene, Iron, Stone, Taney and Washington counties as plaintiffs in the suit.

Numerous drug makers and pharmacies are named as defendants, including Walgreens and CVS, Purdue Pharma and Teva Pharmaceuticals. Jack Garvey, a St. Louis attorney representing the governments, said the defendants “flooded” Joplin and Jasper County with prescription opioids in recent years.

“These companies created a bonfire full of toxic chemicals right in Joplin and walked away from it,” he said. “And it’s spreading noxious fumes and toxic fumes all across the country; they just left and said, ‘Hey, it’s your problem.'”

A Walgreens spokesperson declined to comment, citing a company policy not to discuss pending litigation. Purdue and CVS did not immediately respond to requests for comment.

Elizabeth DeLuca, senior director of corporate communications for Teva, said the company complies with all federal and state regulations with regard to opioids, is working on non-opioid medications for pain relief and frequently coordinates with health care officials and others to prevent drug abuse.

“Teva is committed to the appropriate use of opioid medicines, and we recognize the critical public health issues impacting communities across the U.S. as a result of illegal drug use as well as the misuse and abuse of opioids that are available legally by prescription,” she said.

The Jasper County Commission has called a news conference to discuss the lawsuit. It will begin at 3 p.m. today.

This story is developing and will be updated.

FDA Called Lax in Curbing Use of Powerful Class of Opioids

FDA Called Lax in Curbing Use of Powerful Class of Opioids

https://www.managedcaremag.com/dailynews/20180803/fda-called-lax-curbing-use-powerful-class-opioids

The drugs were approved for cancer patients, but have been prescribed to patients with migraine and back pain, a New York Times investigation reveals.

A class of drugs for cancer patients experiencing “breakthrough pain,” (sudden and sharp onrushes of pain despite the use of standard round-the-clock pain medications), have been prescribed to patients with back pain and migraine, putting them at high risk for addiction, a New York Times investigation says.  

The drugs contain fentanyl, a narcotic up to 50 times stronger than heroin and 100 times stronger than morphine and include Actiq and Fentora, made by Cephalon, and Subsys, made by Insys Therapeutics. The drugs are called T.I.R.F.s (for transmucosal immediate-release fentanyl).

But in what’s being described as a fox guarding the hen house blunder, the FDA in 2011 charged a consortium of drug companies making the products with regulating their use. TheTimes looked at approximately 5,000 pages of documents that researchers at Johns Hopkins University obtained through the Freedom of Information Act. They showed widespread off-label prescribing of the drugs that the FDA did not intervene to prevent. 

Andrew Kolodny, MD, an opioid policy researcher at Brandeis University, told the newspaper that “if any opioids were going to be tightly regulated, it would be these. They had the fox guarding the hen house, people were getting hurt—and the FDA sat by and watched this happen.”

Janet Woodcock, MD, the director of the Center for Drug Evaluation and Research at the FDA, told the newspaper that “the information we have isn’t very good, but it seems to indicate people who aren’t cancer patients are getting this and people who aren’t opioid tolerant are getting this.”

About 115 people in the United States die every day from overdosing on opioids, according to the National Institute on Drug Abuse.

In December 2011, the FDA created a safety program overseeing the use of T.I.R.F.s. “The program required doctors to undergo training for prescribing T.I.R.F.s and to sign a form saying they understood that prescribing to other patients can be dangerous,” the Times reports. “To administer the program, the consortium hired McKesson, a large national distributor that supplies drugs, including T.I.R.F.s, to pharmaceutical retailers.”

McKeeson released a statement in the wake of the investigation saying that it was just doing its job as a third-party administrator and that it was following requirements “developed jointly by the manufacturers and the FDA with ultimate approval resting with the FDA. McKesson administers the program according to these FDA requirements.”

A majority of prescription meds are prescribed “off-label”… because in order the the pharma to get a specific indication for a particular medication they would have to complete clinical trial for the specific disease.  Once the FDA approves a medication to be prescribed, it is considered “safe” for humans and doctors are allowed to prescribe the med for anything they believe will help resolve the health issues for their pts.

Neurontin/Gabapentin was originally approved to treat seizures, but today it is routinely used for neuropathy.

Just how does a pt become opiate tolerant if they are never prescribed a opiate… cancer pts do not become “opiate tolerant” just because they are diagnosed with cancer ?